U.S. citizens are traveling to Havana for a new breakthrough treatment for Alzheimer’s disease. Clinical trials show that, unlike any other medication, Cuba’s NeuralCIM not only stabilizes patients, but in more than half of cases it actually reverses many Alzheimer’s symptoms.